Video | 08 November 2023 Access to insulin pens - Siwar DIABETES MSF has transitioned all patients with type 1 diabetes in our clinics in Lebanon from vials to insulin pens. Here are the stories from patients and staff about how the move has improved both medical outcomes and patients’ quality of life. Read, watch, share Filter by - Any -BlogFeature storyIssue briefLetterPress releaseReport seriesResearch articleStatementTechnical briefVideo Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Anis Al-Bahash 5 min Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Amina 6 min Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Ghassan Fakhri Jabar 7 min Feature story Feature story | 01 November 2024 Diabetes Greece Migrating while managing diabetes: why access to insulin in pens must be available to everyone 2 min Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines Photo credit: Carmen Yahchouchi/MSF Press release Press release | 23 September 2024 Diabetes Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min Load More
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Anis Al-Bahash 5 min
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Amina 6 min
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Ghassan Fakhri Jabar 7 min
Feature story Feature story | 01 November 2024 Diabetes Greece Migrating while managing diabetes: why access to insulin in pens must be available to everyone 2 min
Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min
Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 23 September 2024 Diabetes Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min